(NOVC.DE) Fundamental Analysis & Valuation

FRA:NOVC • DK0060534915

Current stock price

86.34 EUR
-2.03 (-2.3%)
Last:

This NOVC.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. NOVC.DE Profitability Analysis

1.1 Basic Checks

  • NOVC had positive earnings in the past year.
  • In the past year NOVC had a positive cash flow from operations.
NOVC.DE Yearly Net Income VS EBIT VS OCF VS FCFNOVC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 20B 40B 60B

1.2 Ratios

  • The Return On Assets of NOVC (23.95%) is better than 95.56% of its industry peers.
  • NOVC has a better Return On Equity (74.32%) than 95.56% of its industry peers.
  • NOVC has a better Return On Invested Capital (55.96%) than 97.78% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for NOVC is significantly above the industry average of 13.99%.
  • The last Return On Invested Capital (55.96%) for NOVC is above the 3 year average (49.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 23.95%
ROE 74.32%
ROIC 55.96%
ROA(3y)25.55%
ROA(5y)28.51%
ROE(3y)66.85%
ROE(5y)68.54%
ROIC(3y)49.65%
ROIC(5y)55.99%
NOVC.DE Yearly ROA, ROE, ROICNOVC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 20 40 60 80

1.3 Margins

  • Looking at the Profit Margin, with a value of 33.40%, NOVC belongs to the top of the industry, outperforming 91.11% of the companies in the same industry.
  • In the last couple of years the Profit Margin of NOVC has declined.
  • NOVC has a better Operating Margin (42.80%) than 95.56% of its industry peers.
  • NOVC's Operating Margin has been stable in the last couple of years.
  • NOVC has a Gross Margin of 84.35%. This is amongst the best in the industry. NOVC outperforms 84.44% of its industry peers.
  • NOVC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 42.8%
PM (TTM) 33.4%
GM 84.35%
OM growth 3Y-0.97%
OM growth 5Y-0.64%
PM growth 3Y-0.57%
PM growth 5Y-1.67%
GM growth 3Y-0.02%
GM growth 5Y-0.07%
NOVC.DE Yearly Profit, Operating, Gross MarginsNOVC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. NOVC.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), NOVC is creating value.
  • The number of shares outstanding for NOVC has been reduced compared to 1 year ago.
  • The debt/assets ratio for NOVC has been reduced compared to a year ago.
NOVC.DE Yearly Shares OutstandingNOVC.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B 4B
NOVC.DE Yearly Total Debt VS Total AssetsNOVC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 50B 100B 150B 200B

2.2 Solvency

  • NOVC has an Altman-Z score of 11.18. This indicates that NOVC is financially healthy and has little risk of bankruptcy at the moment.
  • NOVC has a better Altman-Z score (11.18) than 93.33% of its industry peers.
  • NOVC has a debt to FCF ratio of 0.38. This is a very positive value and a sign of high solvency as it would only need 0.38 years to pay back of all of its debts.
  • NOVC has a better Debt to FCF ratio (0.38) than 91.11% of its industry peers.
  • A Debt/Equity ratio of 0.21 indicates that NOVC is not too dependend on debt financing.
  • NOVC has a Debt to Equity ratio of 0.21. This is comparable to the rest of the industry: NOVC outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 0.38
Altman-Z 11.18
ROIC/WACC7.69
WACC7.28%
NOVC.DE Yearly LT Debt VS Equity VS FCFNOVC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 20B 40B 60B 80B

2.3 Liquidity

  • NOVC has a Current Ratio of 0.88. This is a bad value and indicates that NOVC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.88, NOVC is doing worse than 84.44% of the companies in the same industry.
  • A Quick Ratio of 0.70 indicates that NOVC may have some problems paying its short term obligations.
  • NOVC has a Quick ratio of 0.70. This is amonst the worse of the industry: NOVC underperforms 82.22% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.7
NOVC.DE Yearly Current Assets VS Current LiabilitesNOVC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 20B 40B 60B 80B 100B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. NOVC.DE Growth Analysis

3.1 Past

  • NOVC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.68%.
  • NOVC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.48% yearly.
  • The Revenue has grown by 28.03% in the past year. This is a very strong growth!
  • Measured over the past years, NOVC shows a quite strong growth in Revenue. The Revenue has been growing by 9.64% on average per year.
EPS 1Y (TTM)-32.68%
EPS 3Y3.69%
EPS 5Y3.48%
EPS Q2Q%-26.37%
Revenue 1Y (TTM)28.03%
Revenue growth 3Y13.19%
Revenue growth 5Y9.64%
Sales Q2Q%31.59%

3.2 Future

  • NOVC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.79% yearly.
  • Based on estimates for the next years, NOVC will show a quite strong growth in Revenue. The Revenue will grow by 13.65% on average per year.
EPS Next Y96.77%
EPS Next 2Y52.67%
EPS Next 3Y40.31%
EPS Next 5Y25.79%
Revenue Next Year27.56%
Revenue Next 2Y22.92%
Revenue Next 3Y20.4%
Revenue Next 5Y13.65%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NOVC.DE Yearly Revenue VS EstimatesNOVC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100B 200B 300B 400B
NOVC.DE Yearly EPS VS EstimatesNOVC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20 40 60 80

More info and screens

Find the best growth stocksShow best growing peers

5

4. NOVC.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 43.17, the valuation of NOVC can be described as expensive.
  • Based on the Price/Earnings ratio, NOVC is valued a bit more expensive than the industry average as 64.44% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Earnings ratio of 27.53, NOVC is valued quite expensively.
  • NOVC is valuated correctly with a Price/Forward Earnings ratio of 15.13.
  • 64.44% of the companies in the same industry are more expensive than NOVC, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 37.95. NOVC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 43.17
Fwd PE 15.13
NOVC.DE Price Earnings VS Forward Price EarningsNOVC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NOVC is valued a bit more expensive than the industry average as 64.44% of the companies are valued more cheaply.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of NOVC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 42.68
EV/EBITDA 30.33
NOVC.DE Per share dataNOVC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of NOVC may justify a higher PE ratio.
  • A more expensive valuation may be justified as NOVC's earnings are expected to grow with 40.31% in the coming years.
PEG (NY)0.45
PEG (5Y)12.41
EPS Next 2Y52.67%
EPS Next 3Y40.31%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NOVC.DE Dividend Analysis

5.1 Amount

  • No dividends for NOVC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

NOVC.DE Fundamentals: All Metrics, Ratios and Statistics

FRA:NOVC (9/19/2023, 5:26:42 PM)

86.34

-2.03 (-2.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap386.28B
Revenue(TTM)201.32B
Net Income(TTM)67.24B
Analysts70.63
Price Target169.94 (96.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP41.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.26%
Min EPS beat(2)-6.63%
Max EPS beat(2)2.11%
EPS beat(4)3
Avg EPS beat(4)-0.09%
Min EPS beat(4)-6.63%
Max EPS beat(4)2.85%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)99180.3%
Min Revenue beat(2)97265.9%
Max Revenue beat(2)101095%
Revenue beat(4)4
Avg Revenue beat(4)100079%
Min Revenue beat(4)97265.9%
Max Revenue beat(4)101151%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.68%
PT rev (3m)6.75%
EPS NQ rev (1m)-50.34%
EPS NQ rev (3m)-49.42%
EPS NY rev (1m)0.22%
EPS NY rev (3m)4.6%
Revenue NQ rev (1m)-99.9%
Revenue NQ rev (3m)-99.9%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)3.71%
Valuation
Industry RankSector Rank
PE 43.17
Fwd PE 15.13
P/S 14.31
P/FCF 42.68
P/OCF 32.1
P/B 31.84
P/tB 72.51
EV/EBITDA 30.33
EPS(TTM)2
EY2.32%
EPS(NY)5.71
Fwd EY6.61%
FCF(TTM)2.02
FCFY2.34%
OCF(TTM)2.69
OCFY3.12%
SpS6.03
BVpS2.71
TBVpS1.19
PEG (NY)0.45
PEG (5Y)12.41
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 23.95%
ROE 74.32%
ROCE 69.41%
ROIC 55.96%
ROICexc 79.18%
ROICexgc 187.85%
OM 42.8%
PM (TTM) 33.4%
GM 84.35%
FCFM 33.53%
ROA(3y)25.55%
ROA(5y)28.51%
ROE(3y)66.85%
ROE(5y)68.54%
ROIC(3y)49.65%
ROIC(5y)55.99%
ROICexc(3y)59.43%
ROICexc(5y)70.56%
ROICexgc(3y)107.14%
ROICexgc(5y)103.87%
ROCE(3y)66.16%
ROCE(5y)72.5%
ROICexgc growth 3Y12.28%
ROICexgc growth 5Y2.92%
ROICexc growth 3Y-8.96%
ROICexc growth 5Y-9.74%
OM growth 3Y-0.97%
OM growth 5Y-0.64%
PM growth 3Y-0.57%
PM growth 5Y-1.67%
GM growth 3Y-0.02%
GM growth 5Y-0.07%
F-Score7
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 0.38
Debt/EBITDA 0.21
Cap/Depr 278.9%
Cap/Sales 11.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 100.38%
Current Ratio 0.88
Quick Ratio 0.7
Altman-Z 11.18
F-Score7
WACC7.28%
ROIC/WACC7.69
Cap/Depr(3y)235.6%
Cap/Depr(5y)244.27%
Cap/Sales(3y)10.33%
Cap/Sales(5y)10.26%
Profit Quality(3y)95.36%
Profit Quality(5y)92.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-32.68%
EPS 3Y3.69%
EPS 5Y3.48%
EPS Q2Q%-26.37%
EPS Next Y96.77%
EPS Next 2Y52.67%
EPS Next 3Y40.31%
EPS Next 5Y25.79%
Revenue 1Y (TTM)28.03%
Revenue growth 3Y13.19%
Revenue growth 5Y9.64%
Sales Q2Q%31.59%
Revenue Next Year27.56%
Revenue Next 2Y22.92%
Revenue Next 3Y20.4%
Revenue Next 5Y13.65%
EBIT growth 1Y29.73%
EBIT growth 3Y12.1%
EBIT growth 5Y8.94%
EBIT Next Year38.11%
EBIT Next 3Y23.19%
EBIT Next 5Y17.5%
FCF growth 1Y112.16%
FCF growth 3Y21.73%
FCF growth 5Y14.55%
OCF growth 1Y65.59%
OCF growth 3Y19.03%
OCF growth 5Y13.89%

/ NOVC.DE Fundamental Analysis FAQ

What is the fundamental rating for NOVC stock?

ChartMill assigns a fundamental rating of 7 / 10 to NOVC.DE.


What is the valuation status of (NOVC.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to (NOVC.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for ?

(NOVC.DE) has a profitability rating of 9 / 10.


Can you provide the expected EPS growth for NOVC stock?

The Earnings per Share (EPS) of (NOVC.DE) is expected to grow by 96.77% in the next year.


How sustainable is the dividend of (NOVC.DE) stock?

The dividend rating of (NOVC.DE) is 4 / 10 and the dividend payout ratio is 41.57%.